BCA
IBB icon

Bay Colony Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bay Colony Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
2,363
+600
+34% +$103K 0.05% 289
2026
Q1 		$298K Hold
1,763
– – 0.04% 388
2025
Q4 		$297K Buy
1,763
+6
+0.3% +$975 0.04% 394
2025
Q3 		$254K Sell
1,757
-161
-8% -$22K 0.03% 428
2025
Q2 		$243K Sell
1,918
-177
-8% -$21.7K 0.03% 396
2025
Q1 		$273K Sell
2,095
-214
-9% -$29K 0.04% 351
2024
Q4 		$305K Buy
2,309
+322
+16% +$45.3K 0.05% 324
2024
Q3 		$289K Sell
1,987
-50
-2% -$7.24K 0.04% 328
2024
Q2 		$280K Sell
2,037
-36
-2% -$4.81K 0.05% 306
2024
Q1 		$284K Sell
2,073
-134
-6% -$18.3K 0.05% 299
2023
Q4 		$300K Sell
2,207
-107
-5% -$13.1K 0.06% 273
2023
Q3 		$283K Sell
2,314
-599
-21% -$76.2K 0.07% 248
2023
Q2 		$370K Buy
2,913
+311
+12% +$40.4K 0.09% 203
2023
Q1 		$331K Sell
2,602
-401
-13% -$52.5K 0.09% 215
2022
Q4 		$394K Sell
3,003
-231
-7% -$29.9K 0.1% 198
2022
Q3 		$378K Sell
3,234
-93
-3% -$11.5K 0.11% 184
2022
Q2 		$413K Sell
3,327
-1,273
-28% -$151K 0.11% 185
2022
Q1 		$599K Buy
4,600
+575
+14% +$74.9K 0.14% 154
2021
Q4 		$614K Buy
4,025
+1,037
+35% +$161K 0.18% 143
2021
Q3 		$483K Buy
2,988
+336
+13% +$56.5K 0.16% 173
2021
Q2 		$434K Sell
2,652
-71
-3% -$10.9K 0.14% 187
2021
Q1 		$410K Buy
2,723
+418
+18% +$66.4K 0.16% 174
2020
Q4 		$349K Buy
2,305
+373
+19% +$53.3K 0.19% 165
2020
Q3 		$262K Buy
1,932
+169
+10% +$22.9K 0.16% 181
2020
Q2 		$241K Buy
+1,763
New +$225K 0.17% 165
2018
Q3 		– Sell
-1,218
Closed -$134K – 504
2018
Q2 		$134K Buy
+1,218
New +$130K 0.09% 201

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bay Colony Advisors's IBB Position: Q2 2026 in Review

Bay Colony Advisors increased its iShares Biotechnology ETF (IBB) stake by 34% in Q2 2026, buying an estimated $103K and bringing the position to 2,363 shares worth $449K. The position accounts for 0.05% of the portfolio, ranked #289.

Bay Colony Advisors first reported a position in IBB in Q2 2018 and has held it in 26 quarters since. The position peaked at $614K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Bay Colony Advisors held 2,363 shares of iShares Biotechnology ETF worth $449K as of Q2 2026.
  • Bay Colony Advisors bought 600 iShares Biotechnology ETF shares in Q2 2026, an estimated $103K.
  • iShares Biotechnology ETF made up 0.05% of Bay Colony Advisors's portfolio in Q2 2026, its #289 holding.
  • Bay Colony Advisors first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 26 quarters since.
  • Bay Colony Advisors's iShares Biotechnology ETF position peaked at $614K in Q4 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.